Before my time, and I think it was a cancer biotech that started at .10 and hit .35 as the high. Different CEO.
Seth stepped in after that disaster and was very close to putting a reverse merge together with a 3D printing companies that one of the largest pharma in the world was a large seed investor was in.
You know the story from there, auditor malpractice - failure to rotate off.
Had the auditor not intentionally concealed the PCAOB investigation and fail to inform TAUG things would have been very different.
TAUG should have won 10 million or more if it went to trial, with punitive damages. Making a mistake is one thing, but the actions they took after the mistake was outrageous. I should post the deposition of Don Cowan, it was very very bad. I think I only posted Meylers but there were more.
I recall you stating that you had rarely see a company do what TAUG did, file 11 quarters and annuals and become a fully reporting company again.
Mistakes were made, but not intentional. Good decisions have also been made. People know what they have here, it is a sub 5 cent stock with some incredible potential. The biggest being a drug trial for nausea. Next a coolaboration with AEGEA, a company that just may have a Covid test so sensitive it virtually eliminates false negatives and only needs a cheek swab.
It was expensive and time consuming to build a product line of CBD gums, but that is what retailers want. Looks like it is starting to pay off.
News 
Market Data 
Discover 
